MAPS is a nonprofit research and educational organization founded in 1986. Sponsored the clinical trials that formed the basis for Lykos Therapeutics' FDA application. Since the 2024 rejection, MAPS has refocused on policy advocacy, therapist training, and international regulatory engagement.